EphA2/SHP2/SOX8 Axis: A Novel Target for Regulation of Migration and Cetuximab Treatment Sensitivity in Oral Squamous Cell Carcinoma
Molecular Carcinogenesis · 2026-08 · 65 (8) · 977-988
DOI: 10.1002/mc.70131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 26.05.2026. Verfasst von Dayong Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Zhengzhou Central Hospital, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Cetuximab, Mouth Neoplasms, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Receptor, EphA2. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan Province Key Scientific and Technological Attack Program.
Abstract (Originalsprache)
The development of resistance to anticancer therapies in cancer cell is a major challenge in the treatment of oral squamous cell carcinoma (OSCC), a common malignant tumor. Erythropoietin‐producing hepatocellular A2 (EphA2) affects several cancers, and this study examined its role in enhancing OSCC. Following screening, EphA2 and SRY‐Box transcription factor 8 (SOX8) knocked down and overexpression cell lines were constructed, followed by treatment with Cetuximab. Quantitative real‐time polymerase chain reaction, western blot, cell counting kit‐8, wound healing, and transwell assay were used to detect the relevant indicators. Co‐immunoprecipitation was used to detect the interaction between EphA2 and SH2 domain‐containing protein‐tyrosine phosphatase‐2 (SHP2). Double luciferase reporter gene experiment and chromatin immunoprecipitation experiment were performed to verify the regulatory mechanism of EphA2 and SOX8. The mouse tumor model was established, and the tumor development was observed after plasmid transfection and Cetuximab treatment. EphA2 was highly expressed in OSCC cells, and overexpression of EphA2 up‐regulated SOX8. EphA2 regulated SOX8 and associated protein expression to increase OSCC cell migration and invasion. EphA2 knockdown made OSCC cells more sensitive to Cetuximab, whereas SOX8 overexpression reduced this sensitivity. We found SHP2 bound to SOX8. Down‐regulation of EphA2 decreased tumor growth in mice, increased Cetuximab sensitivity, and overexpression of SOX8/SHP2 decreased Cetuximab sensitivity. OSCC had elevated EphA2 levels, which enhanced cell migration and invasion via SHP2/SOX8 and impaired Cetuximab sensitivity. Down‐regulation of EphA2 decreased tumor growth and enhanced Cetuximab sensitivity, suggesting new OSCC targets and potential treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Zhengzhou Central Hospital, Zhengzhou, Henan, China.
ORCID-Profile: Ketao Zhong
Förderung
- Henan Province Key Scientific and Technological Attack Program
Zitieren
APA
Yan, D., Guo, L., Pei, F., & Zhong, K. (2026). EphA2/SHP2/SOX8 Axis: A Novel Target for Regulation of Migration and Cetuximab Treatment Sensitivity in Oral Squamous Cell Carcinoma. Molecular Carcinogenesis, 65(8), 977-988. https://doi.org/10.1002/mc.70131
Vancouver
Yan D, Guo L, Pei F, Zhong K. EphA2/SHP2/SOX8 Axis: A Novel Target for Regulation of Migration and Cetuximab Treatment Sensitivity in Oral Squamous Cell Carcinoma. Molecular Carcinogenesis. 2026;65(8):977-988. doi:10.1002/mc.70131
BibTeX
@article{Yan2026,
author = {Yan, Dayong and Guo, Lele and Pei, Fei and Zhong, Ketao},
title = {EphA2/SHP2/SOX8 Axis: A Novel Target for Regulation of Migration and Cetuximab Treatment Sensitivity in Oral Squamous Cell Carcinoma},
journal = {Molecular Carcinogenesis},
year = {2026},
volume = {65},
number = {8},
pages = {977--988},
doi = {10.1002/mc.70131}
}
EUVIMED